https://www.selleckchem.com/pr....oducts/acalabrutinib
Clinical surveillance of the prevalence of contact allergy in consecutively patch tested patients is a proven instrument to continually assess the importance of contact allergens (haptens) assembled in a baseline series. To present current results from the European Surveillance System on Contact Allergies, including 13 countries represented by 1 to 11 departments. Anonymized or pseudonymized patch test and clinical data from various data capture systems used locally or nationally as transferred to the Erlangen data centre were poo
Like
Comment
Share
